The aim of the Biomedical Catalyst is to support the development of innovative healthcare products, technologies and processes. These can include (but are not limited to):
- disease prevention and proactive management of health and chronic conditions;
- earlier and better detection and diagnosis of disease, leading to better patient outcomes; and
- tailored treatments that either change the underlying disease or offer potential cures.
The Biomedical Catalyst has four funding strands to support progression of projects from initial concept through to late stage development:
- Early stage
- Late stage
The aim of this competition is to explore and evaluate the commercial potential of an innovative scientific idea or carry out a technical evaluation through to proof of concept in a model system. Projects must focus on the development of a product or process that is an innovative solution to a health and care challenge.This competition combines the feasibility and primer (proof of concept) strands to enable SMEs to apply for projects lasting 3 to 18 months. IUK is also running a combined,early and late stage award competition. Applicants may apply for theearly and late stages without needing to go through feasibility and primer.
Support is available for any life science sector or discipline, including (but not limited to):
- medical technologies and devices;
- stratified healthcare;
- advanced therapies (gene and cell therapies);
- digital health;
- drug discovery;
IUK will fund feasibility studies and industrial research projects in this competition strand.
Deadline: 3 April 2019 at 12:00pm
Those requiring more information should contact the competition helpline on 0300 321 4357 or email email@example.com
Biomedical Catalyst 2019 Round 1: Feasibility and Primer Awards
Innovate UK (IUK)